Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-26 @ 12:23 AM
Study NCT ID:
NCT00383994
Status:
COMPLETED
Last Update Posted:
2019-07-31
First Post:
2006-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-22
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-02
First Submit QC Date:
None
Study First Post Date:
2006-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-29
Last Update Post Date:
2019-07-31
Last Update Post Date Type:
ACTUAL